Display options
Share it on

Sex Med. 2021 Jun;9(3):100334. doi: 10.1016/j.esxm.2021.100334. Epub 2021 Mar 12.

Translation and Validation of the Greek Version of the Antipsychotics and Sexual Functioning Questionnaire (ASFQ).

Sexual medicine

Maria Angelaki, Petros Galanis, Artemis Igoumenou, Eirini Alexiou, Giorgos Alevizopoulos

Affiliations

  1. Department of Education, 251 Hellenic Airforce Hospital, Athens, Greece; Department of Nursing, National and Kapodistrian University of Athens, Athens, Greece. Electronic address: [email protected].
  2. Center for Health Services Management and Evaluation, Department of Nursing, National and Kapodistrian University of Athens, Athens, Greece.
  3. Division of Psychiatry, University College London, London, UK.
  4. Forensic Psychiatric Clinic, Sahlgrenska University Hospital, Gothenburg, Sweden; Center for Ethics, Law, and Mental Health (CELAM), Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
  5. Department of Mental Health and Behavioral Sciences, Department of Nursing, National and Kapodistrian University of Athens, Athens, Greece.

PMID: 33722475 PMCID: PMC8240157 DOI: 10.1016/j.esxm.2021.100334

Abstract

INTRODUCTION: Sexual dysfunction in patients with psychoses may be associated with the psychiatric illness itself (negative symptoms, such as apathy, and avolition), comorbid somatic health, psychosocial factors (stigmatization, discrimination), and the use of psychotropic drugs. In Greece, research into the study of antipsychotic-induced sexual dysfunction is not sufficient.

AIM: This study was conducted to translate and validate the Greek version of the Antipsychotics and Sexual Functioning Questionnaire (ASFQ) in a sample of patients receiving antipsychotic treatment.

METHODS: A "forward-backward translation" method was applied. A pilot study was conducted with 15 outpatients with schizophrenia and bipolar disorder under antipsychotics treatment. Patients also completed the "Subjects' Response to Antipsychotics (SRA)" questionnaire in order to assess the validity of the ASFQ. The ASFQ and the SRA questionnaire were completed twice within 2 weeks.

MAIN OUTCOME MEASURES: Reliability (internal consistency and test-retest) and validity were assessed.

RESULTS: The Greek translation of ASFQ was reliable, with excellent internal consistency (Cronbach's a = 0.90 for men and 0.95 for women in both measurements). In addition, the Spearman correlation coefficient was 1 (P< .001) in all Likert-type questions in both assessments. Finally, Spearman correlation coefficients between ASFQ and SRA were moderately positive to strongly positive (between 0.25 and 1) in both assessments, demonstrating moderate to high validity.

CONCLUSIONS: The Greek version of the ASFQ has proved to be a reliable and valid clinical instrument, hence it can be used in further studies in the Greek population. Angelaki M, Galanis P, Igoumenou A, et al. Translation and Validation of the Greek Version of the Antipsychotics and Sexual Functioning Questionnaire (ASFQ). J Sex Med 2021;9:100334.

Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.

Keywords: Antipsychotics; Schizophrenia; Sexual dysfunction; Translation; Validation

References

  1. Int Clin Psychopharmacol. 2011 May;26(3):130-40 - PubMed
  2. J Clin Psychopharmacol. 2011 Jun;31(3):274-80 - PubMed
  3. Psychol Med. 1990 Nov;20(4):843-8 - PubMed
  4. J Clin Psychiatry. 1995 Apr;56(4):137-41 - PubMed
  5. Acta Psychiatr Scand Suppl. 1987;334:1-100 - PubMed
  6. J Sex Res. 2014;51(4):383-9 - PubMed
  7. World Psychiatry. 2018 Feb;17(1):3-11 - PubMed
  8. Psychoneuroendocrinology. 2003 Apr;28 Suppl 2:109-23 - PubMed
  9. Int Clin Psychopharmacol. 2006 Jan;21(1):63-9 - PubMed
  10. Schizophr Res. 2013 Jun;147(1):175-180 - PubMed
  11. Hum Psychopharmacol. 2008 Apr;23(3):201-9 - PubMed
  12. Psychiatr Prax. 1984 Mar;11(2):49-55 - PubMed
  13. Br J Psychiatry. 2012 Aug;201:131-6 - PubMed
  14. J Psychopharmacol. 2015 Aug;29(8):857-66 - PubMed
  15. Prog Neuropsychopharmacol Biol Psychiatry. 2010 Mar 17;34(2):288-93 - PubMed
  16. Schizophr Bull. 2015 May;41(3):674-86 - PubMed
  17. CNS Drugs. 2007;21(11):911-36 - PubMed
  18. Psychoneuroendocrinology. 2008 Jul;33(6):711-7 - PubMed
  19. Schizophr Bull. 2017 Jan 3;43(2):236-239 - PubMed
  20. Schizophr Res. 2013 Nov;150(2-3):410-5 - PubMed
  21. Hosp Community Psychiatry. 1990 Nov;41(11):1238-41 - PubMed
  22. Int J Neuropsychopharmacol. 2005 Jun;8(2):195-201 - PubMed

Publication Types